Os doentes transplantados renais têm alto risco para desenvolver queratoses actínicas e câncer de pele. Para verificar o efeito quimioprofilático da acitretina estudamos a evolução de 13 doentes transplantados renais com queratoses actínicas múltiplas e história de carcinomas cutâneos submetidos a tratamento por 12 meses (20mg/dia). Fez-se a avaliação clínica e laboratorial regularmente em todo o período do estudo. Realizou-se exame histopatológico, demonstração imuno-histoquímica de sub-populações de linfócitos T (CD4, CD8), células natural killer e células de Langerhans, sua quantificação e comparação em biopsias de pele, sem lesão, de área exposta e protegida do sol antes, após seis e 12 meses de tratamento. Observou-se melhora das lesões cutâneas e ausência de aparecimento de novos tumores em 12 dos 13 pacientes. Não ocorreram alterações laboratoriais relacionadas a função renal, hepatotoxicicidade e hiperlipidemia. Não houve diferenças significativas histopatológicas e da população de linfócitos T e células natural killer da pele exposta e protegida do sol com o tratamento. Verificou-se aumento numérico de células de Langerhans epidérmicas aos 12 meses quando comparado aos da pele antes e após seis meses de tratamento (p = 0,002 e p = 0,003). Em nossa casuística o uso de acitretina em doses baixas foi útil para melhorar o aspecto cutâneo e prevenir lesões cutâneas pré-cancerosas e carcinomas. O aumento das células de Langerhans epidérmicas estaria relacionado ao efeito imunomodular da acitretina. / Renal transplant recipients have an increased incidence of actinic keratosis and skin cancer. In order to examine the chemoprophylatic effects of low-dose acitretin on skin cancer development we submitted 13 renal transplanted patients to acitretin therapy (20 mg/day) for 12 month. The patients were assessed at monthly intervals during the first 6 months and every two months until the 12th month for new skin lesions and for acitretin toxicity. Normal skin biopsies of sun exposed and sun protected area were taken for histopathological exam and submitted to immunohistochemistry technique to demonstrate CD4+ and CD8+ T lymphocytes, natural killer cells and Langerhans cells wich were counted and compared in the beginning, after 6th month and 12th month of the treatment. There was an improvement of actinic keratosis and all patients but one did not develop new skin cancer. Side-effects were well-tolerated and no significant biochemical effects were observed. Although there were no differences in the microscopic aspects of the skin and in the number of CD4+ and CD8+ T lymphocytes and natural killer cells, there was a significant increase in the number of epidermal Langerhans cells after 12 months of acitretin therapy. The data obtained permit us to conclude that low dose acitretin therapy is safe, well-tolerated and partially effective in chemoprophylaxis of skin cancer in renal transplant recipients. The increase in epidermal Langerhans cells observed may be an expression of the immunomodulatory effect of acitretin.

Os sarcomas cutâneos primários são tumores raros e de grande heterogeniedade histológica. Com a evolução da oncologia cutânea e da cirurgia dermatológica, os dermatologistas têm sido cada vez mais requisitados para diagnóstico e orientação terapêutica de tumores menos freqüentes. Entretanto são escassos os estudos sobre o tema, sobretudo na literatura nacional. O presente trabalho apresenta como objetivos estudar casos diagnosticados como sarcoma cutâneo primário pelo Laboratório de Dermatopatologia da Divisão de Dermatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo no período de 1992 a 2002. Os casos levantados foram revisados histologicamente, selecionando 65 casos que foram classificados em subtipos histológicos. Foi realizado revisão de prontuários médicos e estudadas as características demográficas, clínicas, evolutivas, histológicas e imuno-histoquímicas. O sarcoma de Káposi foi excluído deste estudo por possuir características epidemiológicas e etiopatogênicas específicas. Dos 65 casos, 34 foram de dermatofibrossarcoma protuberans (DFSP), 10 angiossarcomas, cinco sarcomas epitelióides, quatro fibroxantomas atípicos, três leiomiossarcomas, três mixofibrossarcomas, dois sarcomas pleomórficos, um fibrohistiocitoma maligno, um lipossarcoma, um rabdomiossarcoma, um fibrossarcoma. A análise dos resultados permitiu avaliar o perfil epidemiológico, clínico, anatomopatológico e imuno-histoquímico dos casos, bem como os tratamentos empregados e evolução dos pacientes. Os achados epidemiológicos deste estudo não diferiram significativamente da bibliografia consultada, demonstrando tratar-se de tumores raros representando cerca de um caso para cada 1000 biópsias neste serviço no mesmo período. Quanto a distribuição por idade e sexo os dados foram superponíveis à literatura com exceção feita ao angiossarcoma que mostrou-se mais freqüente no sexo feminino. A cirurgia micrográfica mostrou ser o melhor método para abordagem terapêutica do DFSP. Os casos de angiossarcoma e sarcoma epitelióide apresentaram pior prognóstico. / Soft tissue tumours represent a heterogeneous group of mesenchymal and neural lesions. The cutaneous presentation of these tumours is rare. With the evolution of dermatologic surgery and cutaneous oncology, dermatologists have emerged as the primary physicians for skin cancers management. The lack of epidemiological data about this topic in the brazilian population guided us to present this study. Our goal was to systematically review cases of primary cutaneous sarcomas diagnosed at the Dermatophatology laboratory of the Dermatology division of Hospital das Clínicas of São Paulo from January 1992 to December 2002. After a thorough chart review we could retrieve demographic and clinical data, histopathological and immunohistochemical characteristics, in addition to the type of treatment, response to treatment and follow up from each case studied. Kapos\'s sarcoma due to its peculiar characteristics was not included in this study. A total of 65 cases of primary cutaneous sarcoma were included. In respect to its pathological characterization 34 cases were diagnosed dermatofibrosarcoma protuberans (DFSP), 10 angiosarcoma, five epithelioid sarcoma, four atipical fibroxanthoma, tree leiomyosarcoma, tree myxofibrosarcoma, two pleomorfic sarcoma, one malignant fibrohistiocytoma, one liposarcoma, one rabdomyossarcoma, one fibrossarcoma. Our findings were in agreement with international published data available after a medline search. In summary, sarcomas with primary cutaneous presentation are rare tumors with an incidence of 0.1% from all the pathology slides received in our service during this period. Angiosarcoma and epithelioid sarcomas had the worse prognosis and micrographic surgery was the best treatment for the DFSP.

O Melanoma é um tipo de neoplasia que se origina de melanócitos normalmente presentes na epiderme. Uma das características do melanoma é a capacidade de adquirir resistência a terapias. As células de melanoma podem aumentar a liberação de vesículas extracelulares (VEs) em resposta ao tratamento com quimioterápicos. A cisplatina (CDDP) e a temozolomida (TMZ) são drogas utilizadas para o tratamento de tumores. Ambas as drogas formam adutos no DNA, mas as vias de sinalização que deflagram a morte celular são distintas. O objetivo desse estudo é investigar a morte celular da linhagem B16-F10 na presença de VEs oriundas de células B16-F10 tratadas com cisplatina CDDP ou TMZ. Inicialmente as VEs oriundas de células de melanoma murino, B16-F10, tratadas com CDDP ou TMZ e seus controles, foram isoladas por ultracentrifugações sucessivas. Para os experimentos in vitro, as células foram tratadas com as drogas em combinação com as respectivas VEs. As amostras foram realizados avaliações de ciclo celular e de morte e ensaio clonogênico. Para os experimentos in vivo, as células B16-F10 foram pré-tratadas com VEs, e posteriormente, as células foram inoculadas via subcutânea em camundongos C57BL/6 e os tumores foram mensurados diariamente. Em nosso estudo concluimos que a metodologia do isolamento de VEs é eficiente. Além disso, observamos que o tratamento com CDDP ou TMZ aumenta a liberação de VEs por células tumorais. Apesar do resultado contraditorio, as VEs liberadas por células tumorais tratadas com quimioterápicos aumentam a capacidade de sobrevivência das células de melanoma in vitro. VEs oriundas de células de melanoma não participam inicialmente da sensibilização à morte de células tumorais causada pelas mesmas drogas, mas a longo prazo, as VEs oriundas de células tratadas com a TMZ podem conferir uma resposta celular de sobrevivência às células tumorais in vitro. In vivo, o resultado é inconclusivo, uma vez que para confirmar se as VEs fazem parte da adaptação tumoral conferindo fenômenos de sobrevivência celular in vivo, é necessário avaliar em outros modelos celulares e animais / Melanoma is a neoplasm derived from melanocytes normally present in the skin specifically in the epidermis. One of the malignancies of melanoma is the ability to acquire chemoresistance. Cisplatin (CDDP) and temozolomide (TMZ) are drugs used for the treatment of tumors. Both drugs can form alkylating adducts in DNA, however, the pathways that trigger cell death are distinct. Tumor cells, including melanoma, may increase the release of extracellular vesicles (EVs) in response to chemotherapeutic treatment. The aim of this study is to investigate the cell death phenomenon in B16-F10 cell line in presence of EVs derived from chemotherapeutic-treated B16-F10 cells. For in vitro experiments, the cells were treated with CDDP or TMZ in combination with EVs from chemotherapictreated samples. For in vivo experiments, B16-F10 cells were exposed to EVs and inoculated subcutaneously in C57BL/6 mice. The growth was measured daily. In this work, we established and characterized VEs released by melanoma cells treated with chemotherapics and we established chemotherapics treatments to isolate EVs for next EVs isolation. Our results showed that CDDP or TMZ treatment increase the release of EVs by tumor cells. The EVs released by melanoma cells after CDDP or TMZ treatment seem to increase the survival capacity of melanoma cells. Thus, we concluded that EVs derived from melanoma cells do not participate in the cell death sensitization induced by CDDP or TMZ. However, EVs derived from TMZ treated cells may offer a survival effect to tumor cells in vitro a long term. In vivo, The result is inconclusive since to confirm how VEs are part of the tumor adaptation conferring cellular survival phenomena in vivo, it is necessary to evaluate in other cellular and animal models

Current ACS guidelines recommend routine screening for cancer (ACS, 2002). Motivation to adhere to guidelines may be different for individuals with and without a family history of melanoma (Jonna, et al., 1998). Prior research examining the relationship between family history and skin cancer detection behaviors (Berwick et al., 1996; Friedman et al., 1993; Oliveria et al., 1999) have failed to utilize a theoretical framework to derive hypotheses. The purpose of the present study was to examine the utility of Protection Motivation Theory (PMT) in explaining intentions to engage in skin cancer screening (SCS) and skin self-examination (SSE). In addition, the present study explored whether PMT variables explained the relationship between having a family history of melanoma and SCS/SSE intentions. The research design was cross-sectional with 101 participants in the positive family history group and 80 participants in the negative family history group. Using a standardized, self-report measure, participants were assessed on demographic characteristics, melanoma risk factors, PMT variables, family history, and SCS/SSE behaviors and intentions. Statistical analyses included descriptive statistics, chi square for categorical variables, t-tests for continuous variables, correlational analyses, and multiple regression analyses. The majority of participants (N = 181) were Caucasian (97%) and female (59%). As expected, findings indicated that greater perceived vulnerability, self-efficacy, and response efficacy were associated with greater SCS intentions (p greater or less than .0001). Additionally, greater self-efficacy and response efficacy were associated with greater SSE intention (p greater or less than .01). Additionally, positive family history individuals reported greater perceived vulnerability, greater self-efficacy, and less perceived severity than negative family history individuals (p greater or less than .01). Individuals with a family history of melanoma also had greater SCS intentions and were more likely to have a healthcare provider who recommended SCS. Finally, perceived vulnerability and self-efficacy partially mediated the relationship between group status and SCS intentions. The present study confirms and extends prior research on psychological factors associated with SCS/SSE intentions and on individuals with a family history of melanoma. Clinical implications and future directions are discussed.

Title from PDF of title page. / Document formatted into pages; contains 117 pages. / Thesis (Ph.D.)--University of South Florida, 2003. / Includes bibliographical references. / Text (Electronic thesis) in PDF format. / ABSTRACT Current ACS guidelines recommend routine screening for cancer (ACS, 2002). Motivation to adhere to guidelines may be different for individuals with and without a family history of melanoma (Jonna, et al., 1998). Prior research examining the relationship between family history and skin cancer detection behaviors (Berwick et al., 1996; Friedman et al., 1993; Oliveria et al., 1999) have failed to utilize a theoretical framework to derive hypotheses. The purpose of the present study was to examine the utility of Protection Motivation Theory (PMT) in explaining intentions to engage in skin cancer screening (SCS) and skin self-examination (SSE). In addition, the present study explored whether PMT variables explained the relationship between having a family history of melanoma and SCS/SSE intentions. / ABSTRACT: The research design was cross-sectional with 101 participants in the positive family history group and 80 participants in the negative family history group. Using a standardized, self-report measure, participants were assessed on demographic characteristics, melanoma risk factors, PMT variables, family history, and SCS/SSE behaviors and intentions. Statistical analyses included descriptive statistics, chi square for categorical variables, t-tests for continuous variables, correlational analyses, and multiple regression analyses. The majority of participants (N = 181) were Caucasian (97%) and female (59%). As expected, findings indicated that greater perceived vulnerability, self-efficacy, and response efficacy were associated with greater SCS intentions (p greater or less than .0001). Additionally, greater self-efficacy and response efficacy were associated with greater SSE intention (p greater or less than .01). / ABSTRACT: Additionally, positive family history individuals reported greater perceived vulnerability, greater self-efficacy, and less perceived severity than negative family history individuals (p greater or less than .01). Individuals with a family history of melanoma also had greater SCS intentions and were more likely to have a healthcare provider who recommended SCS. Finally, perceived vulnerability and self-efficacy partially mediated the relationship between group status and SCS intentions. The present study confirms and extends prior research on psychological factors associated with SCS/SSE intentions and on individuals with a family history of melanoma. Clinical implications and future directions are discussed. / System requirements: World Wide Web browser and PDF reader. / Mode of access: World Wide Web.

Diss. (sammanfattning) Linköping : Univ., 2004. / Härtill 4 uppsatser.

Thesis (Ph. D.) -- University of Texas Southwestern Medical Center at Dallas, 2003. / Vita. Bibliography: References located after each study.

Os sarcomas cutâneos primários são tumores raros e de grande heterogeniedade histológica. Com a evolução da oncologia cutânea e da cirurgia dermatológica, os dermatologistas têm sido cada vez mais requisitados para diagnóstico e orientação terapêutica de tumores menos freqüentes. Entretanto são escassos os estudos sobre o tema, sobretudo na literatura nacional. O presente trabalho apresenta como objetivos estudar casos diagnosticados como sarcoma cutâneo primário pelo Laboratório de Dermatopatologia da Divisão de Dermatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo no período de 1992 a 2002. Os casos levantados foram revisados histologicamente, selecionando 65 casos que foram classificados em subtipos histológicos. Foi realizado revisão de prontuários médicos e estudadas as características demográficas, clínicas, evolutivas, histológicas e imuno-histoquímicas. O sarcoma de Káposi foi excluído deste estudo por possuir características epidemiológicas e etiopatogênicas específicas. Dos 65 casos, 34 foram de dermatofibrossarcoma protuberans (DFSP), 10 angiossarcomas, cinco sarcomas epitelióides, quatro fibroxantomas atípicos, três leiomiossarcomas, três mixofibrossarcomas, dois sarcomas pleomórficos, um fibrohistiocitoma maligno, um lipossarcoma, um rabdomiossarcoma, um fibrossarcoma. A análise dos resultados permitiu avaliar o perfil epidemiológico, clínico, anatomopatológico e imuno-histoquímico dos casos, bem como os tratamentos empregados e evolução dos pacientes. Os achados epidemiológicos deste estudo não diferiram significativamente da bibliografia consultada, demonstrando tratar-se de tumores raros representando cerca de um caso para cada 1000 biópsias neste serviço no mesmo período. Quanto a distribuição por idade e sexo os dados foram superponíveis à literatura com exceção feita ao angiossarcoma que mostrou-se mais freqüente no sexo feminino. A cirurgia micrográfica mostrou ser o melhor método para abordagem terapêutica do DFSP. Os casos de angiossarcoma e sarcoma epitelióide apresentaram pior prognóstico. / Soft tissue tumours represent a heterogeneous group of mesenchymal and neural lesions. The cutaneous presentation of these tumours is rare. With the evolution of dermatologic surgery and cutaneous oncology, dermatologists have emerged as the primary physicians for skin cancers management. The lack of epidemiological data about this topic in the brazilian population guided us to present this study. Our goal was to systematically review cases of primary cutaneous sarcomas diagnosed at the Dermatophatology laboratory of the Dermatology division of Hospital das Clínicas of São Paulo from January 1992 to December 2002. After a thorough chart review we could retrieve demographic and clinical data, histopathological and immunohistochemical characteristics, in addition to the type of treatment, response to treatment and follow up from each case studied. Kapos\'s sarcoma due to its peculiar characteristics was not included in this study. A total of 65 cases of primary cutaneous sarcoma were included. In respect to its pathological characterization 34 cases were diagnosed dermatofibrosarcoma protuberans (DFSP), 10 angiosarcoma, five epithelioid sarcoma, four atipical fibroxanthoma, tree leiomyosarcoma, tree myxofibrosarcoma, two pleomorfic sarcoma, one malignant fibrohistiocytoma, one liposarcoma, one rabdomyossarcoma, one fibrossarcoma. Our findings were in agreement with international published data available after a medline search. In summary, sarcomas with primary cutaneous presentation are rare tumors with an incidence of 0.1% from all the pathology slides received in our service during this period. Angiosarcoma and epithelioid sarcomas had the worse prognosis and micrographic surgery was the best treatment for the DFSP.

Orientador: Patrícia Moriel / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-26T00:37:20Z (GMT). No. of bitstreams: 1 Freitas_BetaniadeJesuseSilvadeAlmendra_D.pdf: 2657931 bytes, checksum: d4646bbc60ccc13e11ca7d806b4f75dc (MD5) Previous issue date: 2014 / Resumo: Estudos acerca da influência do estresse oxidativo sobre o equilíbrio cutâneo, sobretudo por seus efeitos devastadores sobre a integridade da pele, são essenciais para a proposição de estratégias de intervenção preventivas para o desenvolvimento do câncer de pele. O objetivo do estudo foi comparar o estresse oxidativo de indivíduos que tiveram e não tiveram câncer de pele não melanoma e avaliar o efeito da suplementação combinada de vitaminas C, E e mineral Zinco no estresse oxidativo de indivíduos que apresentaram a doença. O estudo foi dividido em duas fases: a fase 1 foi um estudo transversal com controles, cuja população foi constituída por pessoas saudáveis (n = 24) e o grupo caso constituído por indivíduos que apresentaram câncer de pele não melanoma já submetidas a tratamento cirúrgico (n = 60). E a fase 2, um ensaio clínico randomizado e duplo cego, no qual os pacientes do grupo caso foram randomizados em dois subgrupos: grupo placebo (n = 34) e grupo suplementado (n = 26) com 50 mg de vitamina C, 60 mg de vitamina E e 40 mg de Zinco durante 8 semanas. As amostras de sangue dos sujeitos foram obtidas no período basal e após intervenção para a avaliação dos biomarcadores de estresse oxidativo (F2-isoprostano, nitrito, substâncias reativas ao ácido tiobarbitúrico (TBARS) e capacidade antioxidante total). O consumo alimentar habitual e o estado nutricional dos sujeitos foram avaliados. Para identificação dos fatores associados ao câncer de pele foi utilizada a análise de regressão logística univariada e multivariada. O nível de significância adotado para este estudo foi de 5%. A maioria dos pacientes estudados foram do sexo feminino com idade superior a 50 anos. Os pacientes do grupo caso apresentaram mais elevadas concentrações séricas dos biomarcadores de estresse oxidativo, sendo que as concentrações de F2-isoprostano estavam significativamente mais elevadas em comparação com os controles. Após suplementação não houve diferença estatística entre os grupos placebo e suplementado em relação aos marcadores de estresse oxidativo. A idade e o F2-isoprostano podem ser marcadores de risco para o câncer de pele não melanoma, a cada ano a mais para o fator idade aumenta em 12% a chance de câncer e cada unidade a mais na medida do marcador aumenta em 4% a chance de câncer. Os resultados mostraram prevalência de sobrepeso no grupo controle com diferença estatística significativa em relação ao grupo caso. As concentrações dietéticas dos minerais antioxidantes zinco, cobre e selênio do grupo caso foram estatisticamente inferiores em relação aos controles e não houve diferença estatística nas concentrações dietéticas dos nutrientes antioxidantes entre os grupos suplementado e placebo. Este estudo sugere que pessoas diagnosticadas com câncer de pele não melanoma e que no momento da realização da pesquisa não mais apresentavam a doença, mostravam elevado estresse oxidativo, quando comparadas a pessoas saudáveis. A suplementação de antioxidantes pelo período de tempo realizado no trabalho não provocou redução significativa nas concentrações dos marcadores de estresse oxidativo dos pacientes. O estudo ainda sugere que o marcador de estresse oxidativo F2-isoprostano pode ser utilizado como um fator de risco para o desenvolvimento do câncer de pele não melanoma / Abstract: Studies investigating the influence of oxidative stress on skin homeostasis, especially for its devastating effects on skin integrity, are essential for the development of preventive intervention strategies for skin cancer. The goal of this study was to compare the concentrations of oxidative stress biomarkers in blood between individuals with and without non-melanoma skin cancer and evaluate the effect of combined supplementation with vitamins C, E, and the mineral zinc on oxidative stress in skin-cancer patients. The study was divided into two stages: stage 1 was cross-sectional study with controls, whose population consisted of healthy individuals (n = 24) and the case group included individuals who had non-melanoma skin cancer undergoing surgery (n = 60). And the second phase a randomized, double blind clinical trial where patients in the case group were randomized into two subgroups: placebo (n =34) and a supplemented group (n = 26) who received 50 mg of vitamin C, 60 mg of vitamin E, and 40 mg of zinc for 8 wk. Blood samples were taken from the subjects before and after intervention to evaluate levels of oxidative stress biomarkers (F2-isoprostane, nitrite, thiobarbituric acid reactive substances (TBARS) and total antioxidant capacity. The usual food consumption and nutritional state of the subjects were also evaluated. Multivariate and univariate logistics regression analysis were used to identify factors associated with the development of skin cancer. The level of significance adopted for this study was 5%. The majority of participants were women over the age of 50. The patients in the case group had higher serum concentrations of oxidative stress biomarkers, and the levels of F2-isoprostane were significantly higher than the controls. After antioxidant supplementation there was no statistical difference in the markers of oxidative stress among the placebo and supplemented groups. Age and F2-isoprostane may be effective biomarkers for estimating the risk of non-melanoma skin cancer development. Moreover, the risk of cancer increases with age at a rate of 12% per year, while an increase in concentration of these biomarker in blood increases the risk of cancer by 4%. These results showed a prevalence of excess weight in the control group with significant statistical difference from the case group. The dietary intake of the mineral antioxidants zinc, copper, and selenium of the case group were significantly lower than the control group, and there was no statistical difference in the dietary intake of the antioxidant nutrients among the supplemented and placebo groups. This study suggests that people diagnosed with non-melanoma skin cancer and those in remission at the time of the study, exhibited higher concentration oxidative stress than healthy individuals. The antioxidant supplementation by period the work performed did not cause significant reduction in serum concentrations of oxidative stress biomarkers of the patients. The results suggest that the concentration of the oxidative stress biomarker, F2-isoprostane, may serve as risk factor for non-melanoma skin cancer development / Doutorado / Ciencias Biomedicas / Doutora em Ciências Médicas

<p>Uvod: Od kada je prvi put opisan pre 30 godina, kod porodica obolelih od melanoma<br />kože, displastični nevus je predmet debate. Klinički najznačajnija kontroverza je da se<br />displastični nevus klinički često smatra sumnjivim i da se te&scaron;ko razlikuje od ranog<br />melnoma kože. Ovakav klinički izgled displastičnog nevusa je razlog čestih nepotrebnih<br />ekscizija, jednog od najče&scaron;ćih nevusa čoveka. Ciljevi: Ispitati kliničke i dermoskopske karakteristike patohistolo&scaron;ki potvrđenih displastičnih nevusa, i utvrditi učestalost displastičnih nevusa među sumnjivim melanocitnim lezijama koje su odabrane kliničko-dermoskopskim pregledom. Metode: U analitičkoj kliničkoj studiji, u prospektivnom delu, koristili smo kliničko-dermoskospki pristup po predloženom protokolu za selekciju sumnjivih melanocitnih lezija za eksciziju. Ekscidirano je 279 lezija. Od ukunog broja, 83 su bile lezije veoma sumnive na melanom kože, kod 116 lezija melanom nije mogao biti isključen u diferencijalnoj dijagnozi, a 80 lezija su imponovale dobroćudne i ekscidirane su zbog smetnji koje su pričinjavale pacijentu. Klinički su lezije opisivane prema ABCD akronimu (A za asimetriju, B za nepravilnost ivica, C za nepravilnu prebojenost i D za veličinu preko 5 mm). Za dermoskopski opis lezija su korisćeni algoritmi Analiza struktura i Lista od sedam tačaka. Rezultati: Nakon histopatolo&scaron;kog pregleda ekscidiranih 279 lezija, 242 lezije su bile nevusi, od kojih 131 displastični nevus, koji je analiziran posebno za potrebe ove studije, dok su 47 lezija činili melanomi kože. Histopatolo&scaron;ki potvrđeni displastični nevusi su proistekli dominantno iz grupa lezija kliničko-dermoskospki upućenih kao sumnjive na melanom ili iz grupe gde melanom nije mogao biti isključen u diferencijalnoj dijagnozi OR 2,49 (95%CI 1,51-4,11) p=0,0003. Svako ispitano kliničko obeležje ponaosob i u svim mogućim kombinacijama, je bilo od značaja samo za melanoma kože p&lt;0,0001. Nije bilo značajnih razlika u grupi displastičnih nevusa i ostalih nevusa. Displastične nevuse su činile sumnivim njihove dermoskopske karakteristike. Kod ovih nevusa je bila če&scaron;ća multikomponentna struktura OR 4,84 (95%CI 2,87-8,16) p&lt;0,0001 i nepravilne globule OR 7,32 (95%CI 3,35-15,99) p&lt;0,0001. Nepravilne mrlje su uočene kod 90/96 displastičnih nevusa i kod 41/47 melanoma bez značajne razlike. Zaključak: Klinički displastični nevusi nisu imali kliničke karakteristike koje se obično koriste za njihov opis, te klinički nisu imali znake sumnjivih lezija. Klinički su izgledali poput banalnih nevusa. Kombinovani kliničko-dermoskospki pristup za odabir sumnjivih lezija je ukazao na značaj nekih dermoskospkih obeležja. Multikomponentna struktura i nepravilne globule su se vi&scaron;e javljale kod displastičnih nevusa. Poseban je značaj nepravilnih mrlja koje su podjednako često bile uočavane i kod displastičnih nevusa i tankih melanoma.</p> / <p>Background: Dysplastic nevus, a benign melanocytic lesion has been a matter of debate over the last thirty years, since its first description in families with melanoma. The most important controversy is that dysplastic nevus is usually considered to be suspicious, not easily distinguishable from early melanoma by its clinical appearance. This is followed by numerous unnecessary excisions of a nevus that is considered to be one of the most common in humans. Objectives: To describe the clinical and dermoscopic characteristics of dysplastic nevus, and&nbsp; to&nbsp; investigate&nbsp; its&nbsp; proportion&nbsp; in&nbsp; suspicious&nbsp; melanocytic&nbsp; lesions&nbsp; using clinicodermoscopic approach. Methods: In an analytical clinical study, in the prospective part of the study, we used a combined&nbsp; clinicodermoscopic&nbsp; approach&nbsp; according&nbsp; to&nbsp; a&nbsp; proposed&nbsp; protocol,&nbsp; to&nbsp; select lesions for excision. A total of 279 lesions were excised. Of the total number, 83 were very suspicious for melanoma, 116 where melanoma could not be excluded, and eighty were considered to be benign. Still they were excised because they were a burden for patients. Clinical appearance was studied using ABCD acronym (A for assimetry, B for border&nbsp; irregularity,&nbsp; C&nbsp; for&nbsp; color&nbsp; variegation,&nbsp; and&nbsp; D&nbsp; for diameter&nbsp; of&nbsp; more&nbsp; than&nbsp; 5mm). Dermoscopic&nbsp; description&nbsp; of&nbsp; lesions&nbsp; was&nbsp; performed&nbsp; according&nbsp; to&nbsp; algorithms Pattern Analysis and Seven-point Checklist. Results:&nbsp; After&nbsp; histopathological&nbsp; analysis&nbsp; of&nbsp; the&nbsp; 279&nbsp; lesions,&nbsp; 242&nbsp; lesions&nbsp; were&nbsp; nevi, among them 131 dysplastic nevi that were analyzed separately for the purpose of this study and 47 lesions were skin melanoma. Histopathologicaly proven dysplastic nevus originated mainly from a group of lesions clinicodermoscopily recognized as suspicious of melanoma, or a group where melanoma could not be excluded OR 2.49 (95%CI 1.51-4.11) p=0.0003. Each examined clinical feature alone or in any possible combination of features&nbsp; was&nbsp; important&nbsp; only&nbsp; for&nbsp; melanoma&nbsp; p&lt;0.0001.&nbsp; There&nbsp; were&nbsp; no&nbsp; significant differences between dysplastic nevus group and a group of nevi. Dermoscopic features were more important for the overall suspicious&nbsp; appearance. Multicomponent structure OR&nbsp; 4.84&nbsp; (95%CI&nbsp; 2.87-8,16)&nbsp; p&lt;0.0001&nbsp; and&nbsp; irregular&nbsp; globules&nbsp; OR&nbsp; 7.32&nbsp; (95%CI&nbsp; 3.35-15.99)&nbsp; p&lt;0.0001&nbsp; were&nbsp; frequent.&nbsp; Irregular&nbsp; blotches&nbsp; were&nbsp; found&nbsp; in&nbsp; 90/96&nbsp; and 41/47, dysplastic nevus and melanoma respectively, without significant differences. Conclusion:&nbsp; Clinically&nbsp; dysplastic&nbsp; nevi&nbsp; did&nbsp; not&nbsp; show&nbsp; clinical&nbsp; characteristics&nbsp; that&nbsp; were usually used to describe them, and did not show signs of suspicious lesions. Clinically, they looked more like banal nevi. The commbined clinicodermoscopic approach to select suspicious melanocytic lesions, revealed some dermoscopic features that were often seen in dysplastic nevi, like the multicomponent structure and the irregular globules, while the irregular blotches were a feature shared both by dysplastic nevi and melanoma.</p>